Green Fluorescent Protein (GFP) Virus-Like Particles (VLPs)

Green Fluorescent Protein (GFP) Virus-Like Particles (VLPs) represent an innovative application of VLP technology, where VLPs are engineered to incorporate GFP. GFP is a protein originally isolated from the jellyfish Aequorea victoria, which emits bright green fluorescence when exposed to light in the blue to ultraviolet range. Integrating GFP into VLPs enhances their visibility under specific light conditions, making these VLPs powerful tools in research for tracking and visualization purposes.

  • Structure:
    • Protein Composition: GFP VLPs typically consist of a viral capsid protein capable of self-assembly, into which GFP is incorporated either by genetic fusion or chemical linkage. Common capsid proteins used are from viruses like Hepatitis B virus or bacteriophages.
    • Capsid: The VLP structure is maintained, with GFP molecules embedded within or attached to the capsid, allowing the particles to retain the fluorescent properties of GFP while mimicking the size and shape of viruses.
  • Production:
    • Expression Systems: GFP VLPs are often produced in bacterial systems like E. coli or in yeast due to the simplicity of inserting the GFP gene into the plasmids used in these systems. Insect cells using baculovirus vectors can also be used to achieve higher expression levels and proper folding of complex VLPs.
    • Purification: Standard purification methods include ultracentrifugation and affinity chromatography, tailored to ensure that the fluorescent properties of GFP are not compromised during the process.
  • Applications:
    • Research Tools: GFP VLPs are primarily used as research tools in cell biology and virology. They allow scientists to visually track the VLPs in cellular environments, facilitating studies on viral entry, trafficking, and intracellular localization.
    • Educational Use: In educational settings, GFP VLPs can demonstrate viral behavior and particle tracking in real-time, providing a vivid illustration of theoretical concepts.
    • Diagnostic Development: GFP VLPs can help in developing new diagnostic tools where visualization of particle binding and interaction is crucial.
  • Immunogenicity:
    • Immune Response: While GFP VLPs are not typically designed to elicit a specific immune response, their presence and behavior in biological systems can still be studied immunologically if combined with antigens.
  • Advantages:
    • Visualization: The incorporation of GFP allows for easy visualization under fluorescence microscopy, enhancing the utility of VLPs in complex biological experiments.
    • Safety: GFP VLPs are non-infectious and safe for use in a wide range of experimental settings.
  • Challenges:
    • Stability of Fluorescence: Maintaining the stability and intensity of GFP fluorescence over time and under different experimental conditions can be challenging.
    • Production Efficiency: The fusion of GFP to capsid proteins can sometimes hinder the assembly efficiency or stability of the VLPs, requiring optimized protocols and expression systems.

AffiVLP® HIV1 VLP (Gag; GFP Proteins)
CAT# AFG-VLP-214
Size: 100 µg
For Price Contact info@affigen.com 0.0 USD
AffiVLP® HIV1 VLP (Gag; EGFP Proteins)
CAT# AFG-VLP-213
Size: 100 µg
For Price Contact info@affigen.com 0.0 USD
For Price Contact info@affigen.com 0.0 USD
For Price Contact info@affigen.com 0.0 USD
For Price Contact info@affigen.com 0.0 USD